RAKESH AMETA

Dr. RAKESH AMETA

orcid

Research Focus & Metrics

Academic Career Length

14Years (2013-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
17 February 2023 in Colloids and Interfaces
Verified
Journal Article
Open access
PDF file
RARAKESH AMETA
RAKESH AMETA
KSKUNJAL SONI
KUNJAL SONI
Ajaya BhattaraiAjaya Bhattarai
Ajaya Bhattarai
Formulations based on emulsions for enhancing hydrophobic and lipophilic drug delivery and its bioavailability have attracted a lot of interest. As potential therapeutic agents, they are integrated with inert oils, emulsions, surfactant solubility, liposomes, etc.; drug delivering systems that use emulsion formations have emerged as a unique and commercially achievable accession to override the issue of less oral bioavailability in connection with hydrophobic and lipophilic drugs. As an ideal isotropic oil mixture of surfactants and co-solvents, it self-emulsifies and forms fine oil in water emulsions when acquainted with aqueous material. As droplets rapidly pass through the stomach, fine oil promotes the vast spread of the drug all over the GI (gastrointestinal tract) and conquers the slow disintegration commonly seen in solid drug forms. The current status of advancement in technologies for drug carrying has promulgated the expansion of innovative drug carriers for the controlled release of self-emulsifying pellets, tablets, capsules, microspheres, etc., which got a boost for drug delivery usage with self-emulsification. The present review article includes various kinds of formulations based on the size of particles and excipients utilized in emulsion formation for drug delivery mechanisms and the increase in the bioavailability of lipophilic/hydrophobic drugs in the present time.


1 May 2013 in The Journal of Chemical Thermodynamics
Verified
Journal Article
Closed access
RARAKESH AMETA
RAKESH AMETA
MSMan Singh
Man Singh
RKR.K. Kale
R.K. Kale

1 August 2016 in Journal of Molecular Liquids
Verified
Journal Article
Closed access
PMParth Malik
Parth Malik
RARAKESH AMETA
RAKESH AMETA
MSMan Singh
Man Singh

14 March 2013 in New Journal of Chemistry
Verified
Journal Article
Closed access
PDF file
RARAKESH AMETA
RAKESH AMETA
MSMan Singh
Man Singh
RKRaosahab Kathalupant Kale
Raosahab Kathalupant Kale
A series of benzylamine derivative (BAD) supported platinum(IV) complexes (PtCl4(BADs)2) have been synthesized. The complexes were tested in vitro against the MCF-7 cell line, and the 4-fluoro and 4-chloro containing complexes expressed impressive anticancer activities. Their DNA binding nature for a structure–activity relationship (SAR) study was investigated with physicochemical-indicators (PCI) which categorized them as good intercalators for host–guest chemistry. A mechanism for drug efficacy is proposed by analysis of the resultant viscosity and surface tension of PtCl4(BADs)2–DNA solutions named as the drug-friccohesity interaction (DFI). The complexes have shown significant antioxidant activity, determined on the basis of free radical scavenging effects due to their terminating action against the reactive species.